SOOLANTRA (ivermectin) Galderma labs lp Patent: 7,550,440 Expiration: Apr 22, 2024 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of April 21, 2024 Read Post »
Annual Drug Patent Expirations for SOOLANTRA Soolantra is a drug marketed by Galderma Labs Lp and is included in one
New patent expiration for Galderma Labs drug SOOLANTRA Read Post »
Annual Drug Patent Expirations for MEGACE+ES Megace Es is a drug marketed by Endo Pharms Inc and is included in
New patent expiration for Endo Pharms drug MEGACE ES Read Post »
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It
New patent expiration for Nalpropion drug CONTRAVE Read Post »
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one
New patent expiration for Optinose Us drug XHANCE Read Post »
Annual Drug Patent Expirations for EVEKEO+ODT Evekeo Odt is a drug marketed by Azurity and is included in one NDA.
New patent expiration for Azurity drug EVEKEO ODT Read Post »
Annual Drug Patent Expirations for DEXILANT Dexilant is a drug marketed by Takeda Pharms Usa and is included in two
New patent expiration for Takeda Pharms drug DEXILANT Read Post »
Annual Drug Patent Expirations for DEXILANT+SOLUTAB Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in
New patent expiration for Takeda Pharms drug DEXILANT SOLUTAB Read Post »
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA.
New patent expiration for Astrazeneca Ab drug FARXIGA Read Post »
Get fresh news and insights, drug patent expirations & more…
